Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Fallopian Tube”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00006391
What this trial is testing

Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NYU Langone Health
Not applicableActive Not RecruitingNCT05179824
What this trial is testing

Tempus Priority Study: A Pan-tumor Observational Study

Who this might be right for
Breast CancerProstate CancerBladder Cancer+24 more
Tempus AI 1,000
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT06028932
What this trial is testing

Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients

Who this might be right for
Ovarian Carcinoma
Yale University 20
Early research (Phase 1)Study completedNCT01253681
What this trial is testing

Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer

Who this might be right for
CarcinomaFallopian Tube CancerOvarian Cancer+1 more
Amgen 27
Early research (Phase 1)Study completedNCT00079430
What this trial is testing

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+9 more
National Cancer Institute (NCI) 113
Early research (Phase 1)Study completedNCT01264432
What this trial is testing

Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Adult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Ended earlyNCT00331422
What this trial is testing

Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 7
Not applicableEnded earlyNCT00288275
What this trial is testing

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
Precision Therapeutics 256
Testing effectiveness (Phase 2)Study completedNCT01031381
What this trial is testing

Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
University of Pittsburgh 50
Not applicableLooking for participantsNCT05912972
What this trial is testing

Development and Management of Registry in Patients With Gynecologic Cancer in Korea

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+2 more
Asan Medical Center 13,500
Large-scale testing (Phase 3)Study completedNCT00033605
What this trial is testing

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Who this might be right for
Cervical CancerColorectal CancerDiarrhea+8 more
Alliance for Clinical Trials in Oncology 130
Testing effectiveness (Phase 2)Looking for participantsNCT05739981
What this trial is testing

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Imunon 30
Early research (Phase 1)Not Yet RecruitingNCT07532148
What this trial is testing

Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer
Chong Kun Dang Pharmaceutical 24
Not applicableStudy completedNCT03921658
What this trial is testing

The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
University of Minnesota 255
Early research (Phase 1)Study completedNCT01294293
What this trial is testing

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Malignant Ovarian Mixed Epithelial TumorOvarian Brenner TumorOvarian Clear Cell Cystadenocarcinoma+7 more
Gynecologic Oncology Group 20
Not applicableLooking for participantsNCT03296826
What this trial is testing

Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

Who this might be right for
BRCA1 and/or BRCA2 Variant CarriersOvarian CarcinomaFallopian Tube Carcinoma+1 more
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 600
Early research (Phase 1)Active Not RecruitingNCT02627443
What this trial is testing

Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Metastatic Fallopian Tube CarcinomaMetastatic Ovarian CarcinomaMetastatic Primary Peritoneal Carcinoma+9 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT03314740
What this trial is testing

Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib

Who this might be right for
Ovarian Neoplasms
Mario Negri Institute for Pharmacological Research 123
Early research (Phase 1)Active Not RecruitingNCT04673448
What this trial is testing

Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8BRCA-Associated Malignant Neoplasm+24 more
University of Washington 18
Next Page